CN1330295C - Slow-releasing tablets of oral medicine and preparation thereof - Google Patents

Slow-releasing tablets of oral medicine and preparation thereof Download PDF

Info

Publication number
CN1330295C
CN1330295C CNB2005100376788A CN200510037678A CN1330295C CN 1330295 C CN1330295 C CN 1330295C CN B2005100376788 A CNB2005100376788 A CN B2005100376788A CN 200510037678 A CN200510037678 A CN 200510037678A CN 1330295 C CN1330295 C CN 1330295C
Authority
CN
China
Prior art keywords
slow
layer
release
mesh sieves
oral medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100376788A
Other languages
Chinese (zh)
Other versions
CN1679516A (en
Inventor
杨鹏辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANJING YIHUA PHARMACEUTICAL CO Ltd
Original Assignee
NANJING YIHUA PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANJING YIHUA PHARMACEUTICAL CO Ltd filed Critical NANJING YIHUA PHARMACEUTICAL CO Ltd
Priority to CNB2005100376788A priority Critical patent/CN1330295C/en
Publication of CN1679516A publication Critical patent/CN1679516A/en
Application granted granted Critical
Publication of CN1330295C publication Critical patent/CN1330295C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a slow-release tablet of an oral administration medicine, which is laminated by a blank layer without containing main medicines and a slow-release layer containing the main medicines, wherein the blank layer without containing main medicines is mainly prepared from slow-release materials, adhesive agents and lubricating agents; the slow-release layer containing the main medicines is mainly prepared from high-water solubility oral application medicines, the slow-release materials, the adhesive agents and the lubricating agents; the mass ratio of the blank layer and the slow-release layer is from 0.32 to 2.1:1; the mass proportion of the main medicines in the slow-release layer can be determined by the value of the required dosage of the main medicines, and the mass proportion can be selected from 1% to 75%. After the time curve of blood medicine concentration which is shown after the administration of the slow-release tablet of an oral administration medicine of the present invention is contrasted with that of blood medicine concentration which is shown after the common slow-release tablet of an oral administration medicine is administered, the maintenance time of the blood medicine concentration is long after the slow-release tablet of an oral administration medicine of the present invention is administered, and the concentration is stable. The present invention discloses a preparation method of the slow-release tablet of an oral administration medicine.

Description

A kind of slow-releasing tablets of oral medicine and method for making thereof
One, technical field
The present invention relates to a kind of slow-releasing tablets of oral medicine and preparation method thereof
Two, background technology
Some medicines of Shi Yonging owing to the character of some medicine itself, are made conventional tablet and are taken clinically, can be very fast by metabolism in human body.In order to reach effective therapeutic effect, must increase the number of times of taking of this type of medicine.Will cause the shortcoming that medicining times is many, blood concentration fluctuation is big, side reaction is big like this.In order to improve curative effect of medication, reduce medicining times, guarantee drug safety, these medicines must be made slow releasing tablet.Slow releasing tablet is made the slow releasing tablet of homogeneous usually by the even back of principal agent, slow-release material, binding agent and mix lubricant tabletting.This slow releasing tablet often can not play good slow release effect for the good principal agent of water solublity.
Three, summary of the invention
The present invention provides a kind of double-layered slow releasing tablet at above technical deficiency just.
Technical scheme of the present invention is as follows:
A kind of slow-releasing tablets of oral medicine, it is made of with the slow release layer that contains principal agent is superimposed the blanket layer that does not contain principal agent, wherein, the blanket layer that does not contain principal agent mainly is made up of slow-release material, binding agent and lubricant, the slow release layer that contains principal agent mainly is made up of highly-water-soluble oral medicine, slow-release material, binding agent and lubricant, blanket layer is that 0.32-2.1 is than 1 with the mass ratio of slow release layer, in slow release layer, the principal agent quality accounts for the ratio of slow release layer quality can decide according to the dosage size of principal agent needs, can select for use between 1%-75%.
Specifically, slow-releasing tablets of oral medicine of the present invention, shown in an embodiment of the present invention, by per 1000 tablet qualities: slow-release material is the 50-300 gram in the blanket layer, and binding agent is the 10-50 gram, lubricant is the 1-3 gram; Contain that the highly-water-soluble oral medicine is the 1.5-500 gram in the slow release layer of principal agent, slow-release material is the 80-200 gram, and binding agent is the 5-10 gram, and lubricant is the 0.86-7.1 gram.
Above-mentioned highly-water-soluble oral medicine can be ditropan XL, metformin hydrochloride, Yin Da Paan.
Above-mentioned slow-release material can be Rikemal B 200, hydroxypropyl emthylcellulose (HPMC), ethyl cellulose, or the mixture of their two or more slow-release material.
Above-mentioned binding agent can be sodium carboxymethyl cellulose, polyvinylpyrrolidone K30 (PVP-K30), polyvinylpyrrolidone K90 (PVP-K90), or the mixture of their two or more binding agent.
Above-mentioned lubricant can be magnesium stearate, micropowder silica gel, Pulvis Talci.
Slow-releasing tablets of oral medicine of the present invention can adopt wet method tabletting method for making.
A kind of method for making of slow-releasing tablets of oral medicine of the present invention, it comprises the steps:
Step 1. all placed former, adjuvant under 60 ℃ of conditions dry 4 hours, and it is standby to cross 80 mesh sieves;
Step 2. is mixed the preparation of powder:
1. blanket layer: get slow-release material, binding agent by the charge ratio of blanket layer, by equivalent incremental method mix homogeneously, cross 60 mesh sieves, 1. mixing must mix powder;
2. slow release layer: get highly-water-soluble oral medicine, slow-release material, binding agent by the charge ratio of slow release layer, by equivalent incremental method mix homogeneously, cross 60 mesh sieves, 2. mixing must mix powder;
The preparation of step 3. soft material and wet granular: get mixed powder that step 2 makes 1., mix powder 2., add 20% Diluted Alcohol solution respectively, mediate the system soft material, cross 20 mesh sieves, make wet grain 1. and wet grain 2.;
Step 4. drying and tabletting:
2. 1. the wet grain that step 3 is made placed respectively 50-60 ℃ of oven drying 3-4 hour with wet grain, after crossing 18 mesh sieve granulate, must do granule, add lubricant after weighing respectively, mixing, the wet grain that will be after the drying adds lubricant 1. and wet grain 2. place two hoppers of bi-layer tablet press respectively, compacting promptly gets slow-releasing tablets of oral medicine of the present invention in flakes on bi-layer tablet press.
Slow-releasing tablets of oral medicine of the present invention can adopt the compressing dry granulation method for making.
A kind of method for making of slow-releasing tablets of oral medicine of the present invention, it comprises the steps:
Step 1. all placed former, adjuvant under 60 ℃ of conditions dry 4 hours, and it is standby to cross 80 mesh sieves;
Step 2. is mixed the preparation of powder:
1. blanket layer: get slow-release material, binding agent by the charge ratio of blanket layer, by equivalent incremental method mix homogeneously, cross 60 mesh sieves, 1. mixing must mix powder;
2. slow release layer: get highly-water-soluble oral medicine, slow-release material, binding agent by the charge ratio of slow release layer, by equivalent incremental method mix homogeneously, cross 60 mesh sieves, 2. mixing must mix powder;
Step 3. is done particulate preparation: get mixed powder that step 2 makes 1., mix powder 2., dry granulation respectively;
Step 4. tabletting: behind the granule granulate that step 3 is made, weigh respectively, add lubricant, mixing places two hoppers of bi-layer tablet press respectively with two kinds of granules, and compacting promptly gets slow-releasing tablets of oral medicine of the present invention in flakes on bi-layer tablet press.
Characteristics of the present invention:
1, from pharmaceutical dosage form, general slow releasing preparation mostly adopts the effect that pharmaceutical pack the method in the insoluble macromolecular scaffold of being hidden in is reached slow release.The mechanism that discharges is because thereby the retardation of the slow releasing agent of macromolecular scaffold delays the release of medicine.But, only simply contain and to reach ideal slow release effect for the big medicine of water solublity.For instance:, principal agent and sustained-release matrix are not only reached the good slow release effect by 1: 1 mixed also can cause the heavy overweight problem of sheet if drug content is big; Otherwise even drug content is not high, the ratio of slow releasing agent and principal agent can not play the good slow release effect greater than 10 sometimes.The present invention adopts double-layered slow releasing tablet technology, is hidden in pharmaceutical pack on the basis of high molecular slow-release agent, has increased the not blanket layer of pastille of one deck again, reduced the release area of medicine, reduced the speed of drug release, guaranteed the slow releasing function of medicine, its mechanism is seen accompanying drawing 1.
2, from the angle of absorption of human body, general slow releasing preparation is principal agent and sustained-release matrix uniform mixing, after taking, principal agent in human body from sustained-release matrix to around stripping, reach slow release effect.For the very big medicine of water solublity, increase slow-release material again after sustained-release matrix is increased to a certain degree and can not strengthen slow releasing function.And the present invention has increased the blank slow release layer of one deck, has strengthened the retardation for drug release, can reach ideal slow release effect.
3, will take slow-releasing tablets of oral medicine of the present invention and do contrast (seeing accompanying drawing 2-4) with blood drug level-time graph of taking behind the common slow-releasing tablets of oral medicine, it is long to take the time that the blood drug level of slow-releasing tablets of oral medicine of the present invention keeps as can be seen, and concentration is more steady.
Four, description of drawings
Fig. 1, mechanism of action figure of the present invention;
Fig. 2, metformin hydrochloride double-layer sustained release tablets and ordinary tablet, common slow releasing tablet compare: the blood drug level-time plot after taking;
Fig. 3, ditropan XL double-layer sustained release tablets and ordinary tablet, common slow releasing tablet compare: the blood drug level-time plot after taking;
Fig. 4, Yin Da Paan double-layer sustained release tablets and ordinary tablet, monolayer slow releasing tablet compare: the blood drug level-time plot after taking;
Five, the specific embodiment
Embodiment 1.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, cross 80 mesh sieves, standby; Then, prepared layer one is the pastille blanket layer not: get Rikemal B 200 200g, polyvinylpyrrolidone (PVP) K30 15g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation; Prepared layer two pastille slow-release layers: metformin hydrochloride 500g, Rikemal B 200 150g, polyvinylpyrrolidone (PVP) K30 20g cross 60 mesh sieves by equivalent incremental method mix homogeneously, and dry granulation is weighed; Tabletting: layer one, layer two add 1% magnesium stearate mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000, every hydrochloric metformin 500mg on bi-layer tablet press.Blood drug level-time graph after taking medicine is seen Fig. 2.
Embodiment 2.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, it is standby to cross 80 mesh sieves; Then, prepared layer one is the pastille blanket layer not: get full-bodied hydroxypropyl emthylcellulose 275g, polyvinylpyrrolidone (PVP) K30 15g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation is weighed; Prepared layer two slow release layers: get metformin hydrochloride 500g, hydroxypropyl emthylcellulose 150g, polyvinylpyrrolidone (PVP) K30 15g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation is weighed; Tabletting: layer one, layer two add 1% micropowder silica gel mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000, every hydrochloric metformin 500mg on bi-layer tablet press.Blood drug level-time graph after taking medicine is similar to embodiment's 1.
Embodiment 3.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, it is standby to cross 80 mesh sieves; Then, prepared layer one is the pastille blanket layer not: get ethyl cellulose 300g, polyvinylpyrrolidone (PVP) K30 15g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, water is done binding agent, and wet granulation is weighed; Prepared layer two slow release layers: get metformin hydrochloride 500g, ethyl cellulose 200g, polyvinylpyrrolidone (PVP) K30 10g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, wet granulation is weighed; Tabletting: layer one, layer two add 1% magnesium stearate mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000, every hydrochloric metformin 500mg on bi-layer tablet press.Blood drug level-time graph after taking medicine is similar to embodiment 1.
Embodiment 4.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, it is standby to cross 80 mesh sieves; Then, prepared layer one is the pastille blanket layer not: get Rikemal B 200 200g, polyvinylpyrrolidone (PVP) K90 10g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, wet granulation is weighed; Prepared layer two slow release layers: get ditropan XL 10g, Rikemal B 200 100g, polyvinylpyrrolidone (PVP) K90 10g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, wet granulation is weighed; Tabletting: layer one, layer two add 1% magnesium stearate mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000, every hydrochloric metformin 500mg on bi-layer tablet press.Blood drug level-time graph after taking medicine is seen Fig. 3.
Embodiment 5.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, it is standby to cross 80 mesh sieves; Then, prepared layer one is the pastille blanket layer not: full-bodied hydroxypropyl emthylcellulose 150g, polyvinylpyrrolidone (PVP) K90 20g cross 60 mesh sieves by equivalent incremental method mix homogeneously, and dry granulation is weighed; Prepared layer two slow release layers: get ditropan XL 10g, hydroxypropyl emthylcellulose 80g, polyvinylpyrrolidone (PVP) K30 5g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation is weighed; Tabletting: layer one, layer two add 1% magnesium stearate mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000, every hydrochloric oxibutynin 10mg on bi-layer tablet press.Blood drug level-time graph after taking medicine is similar to embodiment 4.
Embodiment 6.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, it is standby to cross 80 mesh sieves; Then, prepared layer one is the pastille blanket layer not: get ethyl cellulose 200g, polyvinylpyrrolidone (PVP) K90 10g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation is weighed; Prepared layer two slow release layers: get ditropan XL 10mg, hydroxypropyl emthylcellulose 80g, polyvinylpyrrolidone (PVP) K90 3g by equivalent incremental method mix homogeneously, cross 60 mesh sieves; Add 20% Diluted Alcohol solution and make soft material in right amount, the wet grain of the 20 mesh sieve systems of crossing, 50 ℃-60 ℃ dry 3-4 hour, cross 18 mesh sieve granulate, weigh; Tabletting: layer one, layer two add 1% magnesium stearate mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000, every hydrochloric oxibutynin 10mg on bi-layer tablet press.Blood drug level-time graph after taking medicine is similar to embodiment 4.
Embodiment 7.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, it is standby to cross 80 mesh sieves; Then, prepared layer one is the pastille blanket layer not: get Rikemal B 200 70g, sodium carboxymethyl cellulose 50g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, add 20% Diluted Alcohol solution and make soft material in right amount, the wet grain of the 20 mesh sieve systems of crossing, 50 ℃-60 ℃ dry 3-4 hour, cross 18 mesh sieve granulate, weigh; Prepared layer two slow release layers: get Yin and reach handkerchief peace 1.5g, Rikemal B 200 100g, polyvinylpyrrolidone (PVP) K30 8g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation is weighed; Tabletting: layer one, layer two add 1% magnesium stearate mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000 on bi-layer tablet press, and every contains Yin and reaches handkerchief peace 1.5mg.Blood drug level-time graph after taking medicine is seen accompanying drawing 4.
Embodiment 8.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, it is standby to cross 80 mesh sieves; Then, prepared layer one is the pastille blanket layer not: the 50g, polyvinylpyrrolidone (PVP) the K30 50g that get full-bodied hydroxypropyl emthylcellulose cross 60 mesh sieves by equivalent incremental method mix homogeneously, and dry granulation is weighed; Prepared layer two slow release layers: get Yin and reach handkerchief peace 1.5g, hydroxypropyl emthylcellulose 80g, sodium carboxymethyl cellulose 5g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation is weighed; Tabletting: layer one, layer two add 1% magnesium stearate mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000 on bi-layer tablet press, and every contains Yin and reaches handkerchief peace 1.5mg.Blood drug level-time graph after taking medicine is similar to embodiment 7.
Embodiment 9.
At first, former, adjuvant were all placed under 60 ℃ of conditions dry 4 hours, it is standby to cross 80 mesh sieves; Then, prepared layer one is the pastille blanket layer not: get ethyl cellulose 80g, polyvinylpyrrolidone (PVP) K30 50g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation is weighed; Prepared layer two slow release layers: get Yin and reach handkerchief peace 1.5g, ethyl cellulose 120g, sodium carboxymethyl cellulose 10g by equivalent incremental method mix homogeneously, cross 60 mesh sieves, dry granulation is weighed; Tabletting: layer one, layer two add 1% Pulvis Talci mixing respectively, and two hoppers of particle separate device of layer one, layer two are pressed into 1000 on bi-layer tablet press, and every contains Yin and reaches handkerchief peace 1.5mg.Blood drug level-time graph after taking medicine is similar to embodiment 7.

Claims (4)

1. slow-releasing tablets of oral medicine, it is characterized in that: it is made of with the slow release layer that contains principal agent is superimposed the blanket layer that does not contain principal agent, wherein, the blanket layer that does not contain principal agent is mainly by slow-release material, binding agent and lubricant are formed, the slow release layer that contains principal agent is mainly by the highly-water-soluble oral medicine, slow-release material, binding agent and lubricant are formed, blanket layer is that 0.32-2.1 is than 1 with the mass ratio of slow release layer, in slow release layer, the principal agent quality accounts for the ratio of slow release layer quality and can decide according to the dosage size of principal agent needs, can between 1%-75%, select for use, described highly-water-soluble oral medicine is a ditropan XL, metformin hydrochloride, Yin Da Paan, described slow-release material is a Rikemal B 200, hydroxypropyl emthylcellulose, ethyl cellulose, or the mixture of their two or more slow-release material, described binding agent is a sodium carboxymethyl cellulose, polyvinylpyrrolidone K30, polyvinylpyrrolidone K90, or the mixture of their two or more binding agent, in blanket layer, the mass ratio of slow-release material and binding agent is 20: 1~1: 1, in slow release layer, the mass ratio of slow-release material and binding agent is 26.7: 1~7.5: 1, described lubricant is a magnesium stearate, micropowder silica gel, Pulvis Talci, the quality that lubricant adds is 1% of a gross mass.
2. a method for preparing the described slow-releasing tablets of oral medicine of claim 1 is characterized in that it comprises the steps:
Step 1. all placed former, adjuvant under 60 ℃ of conditions dry 4 hours, and it is standby to cross 80 mesh sieves;
Step 2. is mixed the preparation of powder:
1. blanket layer: get slow-release material, binding agent by the charge ratio of blanket layer, by equivalent incremental method mix homogeneously, cross 60 mesh sieves, 1. mixing must mix powder;
2. slow release layer: get highly-water-soluble oral medicine, slow-release material, binding agent by the charge ratio of slow release layer, by equivalent incremental method mix homogeneously, cross 60 mesh sieves, 2. mixing must mix powder;
The preparation of step 3. soft material and wet granular: get mixed powder that step 2 makes 1., mix powder 2., add 20% Diluted Alcohol solution respectively, mediate the system soft material, cross 20 mesh sieves, make wet grain 1. and wet grain 2.;
Step 4. drying and tabletting:
2. 1. the wet grain that step 3 is made placed respectively 50-60 ℃ of oven drying 3-4 hour with wet grain, after crossing 18 mesh sieve granulate, must do granule, add lubricant after weighing respectively, mixing, the wet grain that will be after the drying adds lubricant 1. and wet grain 2. place two hoppers of bi-layer tablet press respectively, compacting promptly gets slow-releasing tablets of oral medicine in flakes on bi-layer tablet press.
3. a method for preparing the described slow-releasing tablets of oral medicine of claim 1 is characterized in that it comprises the steps:
Step 1. all placed former, adjuvant under 60 ℃ of conditions dry 4 hours, and it is standby to cross 80 mesh sieves;
Step 2. is mixed the preparation of powder:
1. blanket layer: get slow-release material, binding agent by the charge ratio of blanket layer, by equivalent incremental method mix homogeneously, cross 60 mesh sieves, 1. mixing must mix powder;
2. slow release layer: get highly-water-soluble oral medicine, slow-release material, binding agent by the charge ratio of slow release layer, by equivalent incremental method mix homogeneously, cross 60 mesh sieves, 2. mixing must mix powder;
Step 3. is done particulate preparation: get mixed powder that step 2 makes 1., mix powder 2., dry granulation respectively;
Step 4. tabletting: behind the granule granulate that step 3 is made, weigh respectively, add lubricant, mixing places two hoppers of bi-layer tablet press respectively with two kinds of granules, and compacting promptly gets slow-releasing tablets of oral medicine in flakes on bi-layer tablet press.
CNB2005100376788A 2005-01-12 2005-01-12 Slow-releasing tablets of oral medicine and preparation thereof Expired - Fee Related CN1330295C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100376788A CN1330295C (en) 2005-01-12 2005-01-12 Slow-releasing tablets of oral medicine and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100376788A CN1330295C (en) 2005-01-12 2005-01-12 Slow-releasing tablets of oral medicine and preparation thereof

Publications (2)

Publication Number Publication Date
CN1679516A CN1679516A (en) 2005-10-12
CN1330295C true CN1330295C (en) 2007-08-08

Family

ID=35066544

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100376788A Expired - Fee Related CN1330295C (en) 2005-01-12 2005-01-12 Slow-releasing tablets of oral medicine and preparation thereof

Country Status (1)

Country Link
CN (1) CN1330295C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101574341B (en) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 Oral solid medicine composition containing ropinirole
CN103462922B (en) * 2012-06-06 2016-01-20 南京亿华药业有限公司 A kind of levetiracetam sustained-release tablets and method for making thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
复方愈创木酚甘油醚双层缓释片释放度及释药机制研究 陈俊、平其能、刘国杰、汪科,中国药学杂志,第34卷第12期 1999 *

Also Published As

Publication number Publication date
CN1679516A (en) 2005-10-12

Similar Documents

Publication Publication Date Title
CN113616624B (en) Empagliflozin metformin sustained release preparation and preparation method thereof
CN102258492B (en) Neostigmine bromide slow release preparation and its preparation method
CN102114005B (en) Tracleer capsule and preparation method thereof
CN1330295C (en) Slow-releasing tablets of oral medicine and preparation thereof
SK284552B6 (en) Three-layer controlled active principle release tablet for oral administration
CN101347413B (en) Quetiapine sustained release tablets and method of preparing the same
HU191738B (en) Process for producing retard compositions containing acetylsalicylic acid
CN106018618B (en) Escitalopram oxalate tablet composition and quality control method
JPH0780754B2 (en) Multi-granular sustained-release tablet
CN1225241C (en) Oral disintegrant tablet and its preparation method
RU2326660C1 (en) Oral pharmaceutical composition memantin (options) and method of preparation (options)
CN102119931A (en) Novel metformin hydrochloride slow-releasing tablet and preparation method thereof
CN102764254B (en) A kind of levetiracetam medicinal composition and preparation method thereof
CN115813874B (en) Preparation method of oral three-way combined hypoglycemic double-release tablet and preparation thereof
CN101474163B (en) Lovastatin and niacin sustained-release preparation and preparation method thereof
CN103462922B (en) A kind of levetiracetam sustained-release tablets and method for making thereof
CN103110601B (en) Gliclazide gastric floating tablet and preparation method thereof
CN103690503B (en) A kind of preparation method of double-layer tablet
CN114533744A (en) Ticagrelor-aspirin compound pellet preparation and preparation method thereof
JP4189044B2 (en) Multiple unit type sustained release tablets
CN101244068B (en) Hemsleyadin sustained-release preparation
KR100735904B1 (en) Tablet composition containing extract of natural herbal plants and its manufacturing process
CN109700775A (en) The preparation method of ranitidine hydrochloride piece
CN104013634A (en) Capsule containing aspirin enteric part and dipyridamole quick-releasing part and preparation method thereof
CN102283829B (en) Anti-malarial medicinal composition and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070808

Termination date: 20180112

CF01 Termination of patent right due to non-payment of annual fee